BTAI’s Market Whiplash: -82.17% YTD Decline, 57.61% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -82.17% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -85.22%. Over the past 30 days, the price of BTAI has fallen by 57.61%. And in the last five days, it has fallen by -30.49%.

The stock of BioXcel Therapeutics Inc (BTAI) is currently priced at $3.83. In the last session, the stock climbed significantly, topping out at $4.25 after opening at $4.14. The day’s lowest price was $3.73 before the stock closed at $4.13.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


BioXcel Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $34.12 on 02/09/23, while the lowest price for the same period was registered at $2.23 on 10/03/23.

52-week price history of BTAI Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. BioXcel Therapeutics Inc’s current trading price is -88.78% away from its 52-week high, while its distance from the 52-week low is 71.75%. The stock’s price range during this time has been between $2.23 and $34.12. The trading volume for the Healthcare sector company’s shares reached about 1.78 million for the day, which was lower than the average daily volume of 3.14 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

BioXcel Therapeutics Inc (BTAI) has experienced a quarterly decline of -3.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 112.10M and boasts a workforce of 183 employees.

BioXcel Therapeutics Inc: Analysts’ Ratings Unveiled

As of right now, 4 analysts are rating BioXcel Therapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.32, with a change in price of -2.56. Similarly, BioXcel Therapeutics Inc recorded 3,456,496 in trading volume during the last 100 days, posting a change of -40.06%.

BTAI Stock Stochastic Average

Today’s raw stochastic average for BioXcel Therapeutics Inc over the last 50 days is 47.20%.This indicates a increase from the raw stochastic average of the past 20 days, which was 45.59%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 53.06% and 57.27%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts